...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.
【24h】

Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study.

机译:在慢性肾脏替代治疗开始之前使用非甾体类抗炎药:一项全国性研究。

获取原文
获取原文并翻译 | 示例

摘要

Nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with severe renal complications, including acute renal failure, reduced glomerular filtration rate and interstitial nephritis. Caution against NSAIDs is therefore recommended in advanced chronic kidney disease. In this study, we examined NSAID use, aetiology and comorbidity among a national cohort of patients before the initiation of chronic renal replacement therapy (RRT).Patients initiated on chronic RRT in the period 1997-2006 were identified in the Danish National Registry on Regular Dialysis and Transplantation, including etiological diagnosis. The use of NSAID before the start of RRT was studied by linkage to the National Prescription Register and comorbidity by linkage to the National Patient Registry.A total of 6663 patients were included in the study, and 2407 patients (36.1%) were prescribed NSAID in the 3?years before the start of RRT. These patients were older (mean age = 63.0 vs 61.4?years) and had a significantly higher degree of comorbidity (Charlson score = 2.85 vs 2.61, p?
机译:非甾体类抗炎药(NSAIDs)可能与严重的肾脏并发症有关,包括急性肾衰竭,肾小球滤过率降低和间质性肾炎。因此,建议在晚期慢性肾脏疾病中谨慎使用NSAID。在这项研究中,我们检查了在开始慢性肾脏替代治疗(RRT)之前的全国患者队列中NSAID的使用,病因和合并症.1997-2006年间在慢性RRT上开始的患者已在丹麦国家定期注册系统中确定透析和移植,包括病因诊断。在RRT开始之前使用NSAID进行了研究,方法是与国家处方登记系统建立联系,并与合并症通过与国家患者登记系统建立联系,共纳入6663例患者,其中2407例患者(36.1%)被处方为NSAID RRT开始前的3年。与未接受NSAIDs治疗的患者相比,这些患者年龄较大(平均年龄= 63.0 vs 61.4?岁),合并症程度明显更高(Charlson评分= 2.85 vs 2.61,p <0.05)。在进行RRT的3年中,每年接受NSAID治疗的患者人数和包括所有NSAID在内的累积中位治疗时间分别稳定在大约20%和40天。在患者中,我们观察到NSAID的广泛使用,并在开始RRT的3年内未受影响的高年发病率。版权? 2012年John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号